[go: up one dir, main page]

NO813407L - Alfa-amylaseinaktivator, fremgangsmaater til dets fremstilling, middel paa basis av denne inaktivator, samt dens anvendelse - Google Patents

Alfa-amylaseinaktivator, fremgangsmaater til dets fremstilling, middel paa basis av denne inaktivator, samt dens anvendelse

Info

Publication number
NO813407L
NO813407L NO813407A NO813407A NO813407L NO 813407 L NO813407 L NO 813407L NO 813407 A NO813407 A NO 813407A NO 813407 A NO813407 A NO 813407A NO 813407 L NO813407 L NO 813407L
Authority
NO
Norway
Prior art keywords
hoe
inactivator
thr
val
amylase
Prior art date
Application number
NO813407A
Other languages
English (en)
Norwegian (no)
Inventor
Laszlo Vertesy
Miroslav Mracek
Gerhard Braunitzer
Heintz Aschauer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803038130 external-priority patent/DE3038130A1/de
Priority claimed from DE19813107106 external-priority patent/DE3107106A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO813407L publication Critical patent/NO813407L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO813407A 1980-10-09 1981-10-08 Alfa-amylaseinaktivator, fremgangsmaater til dets fremstilling, middel paa basis av denne inaktivator, samt dens anvendelse NO813407L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803038130 DE3038130A1 (de) 1980-10-09 1980-10-09 (alpha) -amylaseinaktivatoren sowie verfahren zu ihrer herstellung
DE19813107106 DE3107106A1 (de) 1981-02-26 1981-02-26 (alpha) -amylaseinaktivator und verfahren zu seiner herstellung

Publications (1)

Publication Number Publication Date
NO813407L true NO813407L (no) 1982-04-13

Family

ID=25788382

Family Applications (1)

Application Number Title Priority Date Filing Date
NO813407A NO813407L (no) 1980-10-09 1981-10-08 Alfa-amylaseinaktivator, fremgangsmaater til dets fremstilling, middel paa basis av denne inaktivator, samt dens anvendelse

Country Status (9)

Country Link
US (1) US4451455A (fi)
EP (1) EP0049847B1 (fi)
AU (1) AU542795B2 (fi)
CA (1) CA1172978A (fi)
DE (1) DE3169418D1 (fi)
DK (1) DK446481A (fi)
ES (1) ES505959A0 (fi)
FI (1) FI813108A7 (fi)
NO (1) NO813407L (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5885899A (ja) * 1981-11-16 1983-05-23 Fujirebio Inc アミラ−ゼインヒビタ−およびその製造法
DE3331860A1 (de) * 1983-09-03 1985-03-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von tendamistat
FI844289L (fi) * 1984-01-21 1985-07-22 Hoechst Ag Nya polypeptider med -amylashaemmande verkan, foerfarande foer deras framstaellning, deras anvaendning och farmaceutiska preparat.
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
DE3536182A1 (de) * 1985-10-10 1987-04-16 Hoechst Ag Promotor-anordnung fuer streptomyceten-vektoren
WO1996012730A1 (en) * 1994-10-20 1996-05-02 Industrial Research Limited Separation of amino acids and peptides from protein hydrolysates
JP2007512359A (ja) 2003-11-19 2007-05-17 メタバシス・セラピューティクス・インコーポレイテッド 新規なリン含有甲状腺ホルモン様物質
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
MX2007005137A (es) * 2004-11-23 2007-06-22 Warner Lambert Co Derivados del acido 7-(2h-pyrazol-3-il)-3, 5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de lipidemia.
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
EP2170930B3 (en) 2007-06-04 2013-10-02 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
JP2013528172A (ja) 2010-05-21 2013-07-08 ファイザー・インク ２−フェニルベンゾイルアミド
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US20130345392A1 (en) 2011-03-04 2013-12-26 Pfizer Inc Edn3-like peptides and uses thereof
WO2013133685A1 (en) 2012-03-09 2013-09-12 Biotropics Malaysia Berhad Extract formulations of rhodamnia cinerea and uses thereof
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
CN113121450A (zh) 2014-08-29 2021-07-16 Tes制药有限责任公司 α-氨基-β-羧基粘康酸半醛脱羧酶抑制剂
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
US20180134667A1 (en) 2016-10-14 2018-05-17 TES Pharma S.r.I. Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
IL283182B2 (en) 2018-11-20 2025-10-01 Tes Pharma S R L Alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase inhibitors
MA54261B1 (fr) 2019-01-18 2025-03-28 Astrazeneca Ab Inhibiteurs de pcsk9 et leurs procédés d'utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5125232B1 (fi) * 1965-02-24 1976-07-29
DE2701890C2 (de) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Peptielischer Glycosidhydrolase-Inhibitor aus einem Streptomyceten und seine Verwendung

Also Published As

Publication number Publication date
FI813108L (fi) 1982-04-10
EP0049847A2 (de) 1982-04-21
AU542795B2 (en) 1985-03-14
DE3169418D1 (en) 1985-04-25
EP0049847B1 (de) 1985-03-20
DK446481A (da) 1982-04-10
CA1172978A (en) 1984-08-21
ES8207217A1 (es) 1982-09-01
FI813108A7 (fi) 1982-04-10
AU7615081A (en) 1982-04-22
US4451455A (en) 1984-05-29
ES505959A0 (es) 1982-09-01
EP0049847A3 (en) 1982-08-25

Similar Documents

Publication Publication Date Title
NO813407L (no) Alfa-amylaseinaktivator, fremgangsmaater til dets fremstilling, middel paa basis av denne inaktivator, samt dens anvendelse
JPS6234396B2 (fi)
US11976098B2 (en) Cooked millet prolamin peptide for inhibiting alpha-amylase and alpha-glucosidase
JPS643877B2 (fi)
JPS60152500A (ja) α−アミラ−ゼ抑制作用を有する新規ポリペプチドおよびそれらの製法
US4019960A (en) Process for the production of a saccharase inhibitor
US4339436A (en) α-Amylase inhibitor from a streptomycete and process for its preparation
US3937817A (en) Pharmaceutical compositions containing a saccharase inhibitor
CN118852336A (zh) 一种α-葡萄糖苷酶抑制肽YPIW及其应用
JPH0365362B2 (fi)
JPH0521092B2 (fi)
US5244807A (en) Production of pseudomonas xa cells containing indolyl-3-alkane alpha-hydroxylase
NO853461L (no) Nye alfa-glukosidaseinhibitor, fremgangsmaate til dens fremstilling, dens anvendelse og farmasoeytiske preparater.
US5000953A (en) Biologically active substance
PL91664B1 (fi)
EP0661293A2 (en) Protein having cell growth-stimulating and macrophage chemotactic actions, preparative method therefor and use thereof
NZ198570A (en) Alpha-amylase inactivator
US3995026A (en) Amylase inhibitor
NO781267L (no) Alfa-amylase-inhibitor fra en streptomycet og fremgangsmaate til deres utvinning
NO853460L (no) Nye pseudooligosakkarider med alfa-glukosidasehemmende virkning, fremgangsmaate til deres fremstilling og deres anvendelse samt farmasoeytiske preparater.
FI59815B (fi) Foerfarande foer framstaellning av en alfa-amylas-inhibitor med peptidstruktur
NO873385L (no) Oksiran-pseudooligosakkarider, fremgangsmaate til deres fremstilling, deres anvendelse og farmasoeytiske preparater.
DK143414B (da) Fremgangsmaade til fremstilling af en glycosidhydrolase-inhibitor
JP3448334B2 (ja) 新規生理活性物質ピペラスタチンａおよびその製造法
JPH08245690A (ja) 二糖類分解酵素活性促進ペプチド